BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.
최신 재무제표(Form-10K)에 따르면, BGM Group Ltd의 총 자산은 $53이며, 순손실입니다.
BGM의 주요 재무 비율은 무엇인가요?
BGM Group Ltd의 유동비율은 5.3이고, 순이익률은 -4, 주당 매출은 $3.45입니다.
BGM Group Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
BGM Group Ltd 주요 수익원은 Oxytetracycline & Licorice Products and Traditional Chinese Medicine Derivatives이며, 최신 수익 발표에서 수익은 21,961,282입니다. 지역별로는 China이 BGM Group Ltd의 주요 시장이며, 수익은 25,097,951입니다.